Cargando…
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
BACKGROUND: About half of metastatic colorectal cancers (CRCs) harbor Rat Sarcoma (RAS) activating mutations as oncogenic driver, but the prognostic role of RAS mutations is not fully elucidated. Interestingly, specific hotspot mutations have been identified as potential candidates for novel targete...
Autores principales: | Lavacchi, Daniele, Fancelli, Sara, Roviello, Giandomenico, Castiglione, Francesca, Caliman, Enrico, Rossi, Gemma, Venturini, Jacopo, Pellegrini, Elisa, Brugia, Marco, Vannini, Agnese, Bartoli, Caterina, Cianchi, Fabio, Pillozzi, Serena, Antonuzzo, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745189/ https://www.ncbi.nlm.nih.gov/pubmed/36523988 http://dx.doi.org/10.3389/fonc.2022.1055019 |
Ejemplares similares
-
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing
por: Lavacchi, Daniele, et al.
Publicado: (2023) -
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer
por: Lavacchi, Daniele, et al.
Publicado: (2023) -
Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives
por: Fancelli, Sara, et al.
Publicado: (2021) -
Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience
por: Lavacchi, Daniele, et al.
Publicado: (2021) -
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients
por: Lavacchi, Daniele, et al.
Publicado: (2023)